PhosImmune Inc. (acquired by Agenus)

PhosImmune, Inc. is a cancer immunnotherapy company which was founded to commercialize a library of phosphopeptide tumor targets (PTTs) discovered at the University of Virginia (UVa) and the University of Birmingham (UK). PhosImmune has developed a proprietary PTT screening methodology which allows for rapid identification and selection of PTTs for therapeutic applications.

UVA Founders: Dr. Donald Hunt, Dr. Victor Engelhard